Newron Pharmaceuticals S.p.A.
NWPHF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $30,951 | -$9,557 | -$9,274 | -$6,950 |
| Dep. & Amort. | $96 | $96 | $99 | $102 |
| Deferred Tax | $0 | $0 | $0 | $1,361 |
| Stock-Based Comp. | $86 | $170 | $142 | $55 |
| Change in WC | -$38,221 | $468 | $958 | -$22 |
| Other Non-Cash | -$1,698 | -$5 | $3,538 | $1,212 |
| Operating Cash Flow | -$8,786 | -$8,828 | -$4,537 | -$5,603 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6 | -$7 | -$3 | -$8 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$1,875 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $5,046 | $0 | $0 | $0 |
| Other Inv. Act. | -$2,016 | $2,016 | $3,260 | -$3 |
| Investing Cash Flow | $1,149 | $2,009 | $3,257 | -$11 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $97 | -$97 | $0 | -$97 |
| Stock Issued | $15,414 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$8,838 | $8,475 | -$95 | $0 |
| Financing Cash Flow | $6,673 | $8,378 | -$95 | -$97 |
| Forex Effect | $0 | $0 | -$6,338 | $13,424 |
| Net Chg. in Cash | -$964 | $7,897 | -$7,713 | $7,713 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,897 | $0 | $7,713 | $0 |
| End Cash | $6,933 | $7,897 | $0 | $7,713 |
| Free Cash Flow | -$8,792 | -$8,835 | -$4,540 | -$5,611 |